Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2017, Article ID 9473917, 4 pages
https://doi.org/10.1155/2017/9473917
Case Report

Mitochondrial Cardiomyopathy Presenting as Dilated Phase of Hypertrophic Cardiomyopathy Diagnosed with Histological and Genetic Analyses

1Department of Cardiology, Japanese Red Cross Ashikaga Hospital, Ashikaga, Japan
2Department of Neurology, Japanese Red Cross Ashikaga Hospital, Ashikaga, Japan
3Department of General Internal Medicine, Hiroshima-Nishi Medical Center, Ohtake, Japan
4Department of Internal Medicine, Asahi School of Dentistry University, Mizuho, Japan
5Department of Gastroenterology, Japanese Red Cross Ashikaga Hospital, Ashikaga, Japan
6Department of Cardiology, Jichi Medical University, Shimotsuke, Japan

Correspondence should be addressed to Toshiki Kuno; pj.oc.liamtoh@ikihsot-onuk

Received 3 March 2017; Accepted 4 May 2017; Published 23 May 2017

Academic Editor: Nurten Sayar

Copyright © 2017 Toshiki Kuno et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. E. Meyers, H. I. Basha, and M. K. Koenig, “Mitochondrial cardiomyopathy: pathophysiology, diagnosis, and management,” Texas Heart Institute journal/from the Texas Heart Institute of St Luke’s Episcopal Hospital, Texas Children’s Hospital, vol. 40, no. 1, pp. 385–394, 2013. View at Publisher · View at Google Scholar
  2. M. Nakanishi, M. Harada, E. Tadamura et al., “Mitochondrial cardiomyopathy evaluated with cardiac magnetic resonance,” Circulation, vol. 116, no. 2, pp. e25–e26, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Matsuo, K. Nakajima, S. Knuya, Y. Sato, N. Matsumoto, and M. Horie, “Cardiac scintigraphic findings of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: A case report,” Experimental and Clinical Cardiology, vol. 13, no. 2, pp. 93–95, 2008. View at Google Scholar · View at Scopus
  4. G. Takemura, K. Onoue, T. Kashimura et al., “Electron microscopic findings are an important aid for diagnosing mitochondrial cardiomyopathy with mitochondrial dna mutation 3243A>G,” Circulation Heart failure, vol. 9, no. 7, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Holzmann, A. Nicko, U. Kühl et al., “Complication rate of right ventricular endomyocardial biopsy via the femoral approach: A retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period,” Circulation, vol. 118, no. 17, pp. 1722–1728, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. Y.-H. R. Hsu, H. Yogasundaram, N. Parajuli, L. Valtuille, C. Sergi, and G. Y. Oudit, “MELAS syndrome and cardiomyopathy: linking mitochondrial function to heart failure pathogenesis,” Heart Failure Reviews, vol. 21, no. 1, pp. 103–116, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. A. S. L. Tang, G. A. Wells, M. Talajic et al., “Cardiac-resynchronization therapy for mild-to-moderate heart failure,” New England Journal of Medicine, vol. 363, no. 25, pp. 2385–2395, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. Weng, J. Yao, R. H. Chan et al., “Prognostic Value of LGE-CMR in HCM,” JACC: Cardiovascular Imaging, vol. 9, no. 12, pp. 1392–1402, 2016. View at Publisher · View at Google Scholar